1. Home
  2. AVXL vs KSS Comparison

AVXL vs KSS Comparison

Compare AVXL & KSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • KSS
  • Stock Information
  • Founded
  • AVXL 2004
  • KSS 1962
  • Country
  • AVXL United States
  • KSS United States
  • Employees
  • AVXL N/A
  • KSS N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • KSS Department/Specialty Retail Stores
  • Sector
  • AVXL Health Care
  • KSS Consumer Discretionary
  • Exchange
  • AVXL Nasdaq
  • KSS Nasdaq
  • Market Cap
  • AVXL 794.0M
  • KSS 931.8M
  • IPO Year
  • AVXL N/A
  • KSS 1992
  • Fundamental
  • Price
  • AVXL $12.74
  • KSS $12.92
  • Analyst Decision
  • AVXL Strong Buy
  • KSS Sell
  • Analyst Count
  • AVXL 2
  • KSS 13
  • Target Price
  • AVXL $44.00
  • KSS $8.38
  • AVG Volume (30 Days)
  • AVXL 1.2M
  • KSS 20.6M
  • Earning Date
  • AVXL 08-05-2025
  • KSS 08-27-2025
  • Dividend Yield
  • AVXL N/A
  • KSS 3.67%
  • EPS Growth
  • AVXL N/A
  • KSS N/A
  • EPS
  • AVXL N/A
  • KSS 1.09
  • Revenue
  • AVXL N/A
  • KSS $16,072,000,000.00
  • Revenue This Year
  • AVXL N/A
  • KSS N/A
  • Revenue Next Year
  • AVXL N/A
  • KSS N/A
  • P/E Ratio
  • AVXL N/A
  • KSS $12.52
  • Revenue Growth
  • AVXL N/A
  • KSS N/A
  • 52 Week Low
  • AVXL $4.93
  • KSS $6.04
  • 52 Week High
  • AVXL $14.44
  • KSS $22.53
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 69.01
  • KSS 70.70
  • Support Level
  • AVXL $10.98
  • KSS $11.81
  • Resistance Level
  • AVXL $11.33
  • KSS $21.39
  • Average True Range (ATR)
  • AVXL 0.75
  • KSS 1.30
  • MACD
  • AVXL 0.15
  • KSS 0.43
  • Stochastic Oscillator
  • AVXL 69.36
  • KSS 37.97

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

About KSS Kohl's Corporation

Kohl's operates about 1,150 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also has a large digital sales operation. Women's apparel is Kohl's largest category, having generated 25% of its 2024 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.

Share on Social Networks: